Cargando…
Low-Iodine Diet of 4 Days Is Sufficient Preparation for (131)I Therapy in Differentiated Thyroid Cancer Patients
CONTEXT: No consensus exists about the optimal duration of the low-iodine diet (LID) in the preparation of (131)I therapy in differentiated thyroid cancer (DTC) patients. OBJECTIVE: This work aimed to investigate if a LID of 4 days is enough to achieve adequate iodine depletion in preparation for (1...
Autores principales: | Dekker, Bernadette L, Links, Mirthe H, Muller Kobold, Anneke C, Swart-Busscher, Linda G, Kars, Marleen, Bons, Judith A P, Brouwers, Adrienne H, Links, Thera P, van der Horst-Schrivers, Anouk N A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8764339/ https://www.ncbi.nlm.nih.gov/pubmed/34534327 http://dx.doi.org/10.1210/clinem/dgab691 |
Ejemplares similares
-
Use of Salivary Iodine Concentrations to Estimate the Iodine Status of Adults in Clinical Practice
por: Dekker, Bernadette L, et al.
Publicado: (2021) -
Clinical irrelevance of lower titer thyroglobulin autoantibodies in patients with differentiated thyroid carcinoma
por: Dekker, Bernadette L, et al.
Publicado: (2022) -
The Value of Pre-Ablative I-131 Scan for Clinical Management in Patients With Differentiated Thyroid Carcinoma
por: van der Boom, Trynke, et al.
Publicado: (2021) -
Clinical implications of the oncometabolite succinate in SDHx‐mutation carriers
por: Eijkelenkamp, Karin, et al.
Publicado: (2019) -
Letter to the Editor From Zandee and Links: “Metastatic Differentiated Thyroid Cancer Survival Is Unaffected by Mode of Preparation for (131)I Administration”
por: Zandee, Wouter T, et al.
Publicado: (2023)